Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Return on Equity (2018 - 2025)

Serina Therapeutics (SER) has disclosed Return on Equity for 8 consecutive years, with 31.13% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 3377.0% to 31.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 31.13% through Dec 2025, down 3377.0% year-over-year, with the annual reading at 81.59% for FY2025, 8230.0% down from the prior year.
  • Return on Equity hit 31.13% in Q4 2025 for Serina Therapeutics, down from 14.44% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 2.64% in Q4 2024 to a low of 31.13% in Q4 2025.
  • Historically, Return on Equity has averaged 3.66% across 5 years, with a median of 0.18% in 2023.
  • Biggest five-year swings in Return on Equity: skyrocketed 847bps in 2021 and later tumbled -3377bps in 2025.
  • Year by year, Return on Equity stood at 0.01% in 2021, then skyrocketed by 4117bps to 0.4% in 2022, then crashed by -72bps to 0.11% in 2023, then surged by 2306bps to 2.64% in 2024, then crashed by -1280bps to 31.13% in 2025.
  • Business Quant data shows Return on Equity for SER at 31.13% in Q4 2025, 14.44% in Q3 2025, and 13.93% in Q2 2025.